Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €4.10 EUR
Change Today 0.00 / 0.00%
Volume 0.0
As of 12:46 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

oriola-kd oyj b shares (O5O) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/4/15 - €4.59
52 Week Low
10/10/14 - €2.19
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ORIOLA-KD OYJ   B SHARES (O5O)

Related News

No related news articles were found.

oriola-kd oyj b shares (O5O) Related Businessweek News

No Related Businessweek News Found

oriola-kd oyj b shares (O5O) Details

Oriola-KD Corporation operates as a pharmaceutical retail and wholesale company in Finland, Sweden, and Baltic countries. The company operates in Pharmaceutical Trade Finland and Baltics, and Pharmaceutical Trade Sweden segments. It distributes various pharmaceuticals; and provides various added value services for pharmaceutical manufacturers and pharmacies, such as distribution of clinical trials medicines and medical samples, as well as storage and distribution services for marketing materials, and other solutions. The company also sells and markets consumer health products that comprise vitamins, dietary supplements, pharmacy cosmetics, skincare products, tests, sports drinks, and wound care products. It serves primarily pharmaceutical companies and other product manufacturers, pharmacies, veterinary practices, grocery stores, health stores, hospitals, and healthcare personnel. As of December 31, 2014, the company had 304 pharmacies in Sweden. Oriola-KD Corporation is headquartered in Espoo, Finland.

2,312 Employees
Last Reported Date: 07/17/15

oriola-kd oyj b shares (O5O) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: €569.7K
Compensation as of Fiscal Year 2013.

oriola-kd oyj b shares (O5O) Key Developments

Oriola-KD Corporation Appoints Members to its Nomination Committee

The Board of Directors of Oriola-KD Corporation has on 25 September 2015 appointed the following persons as members of the company's Nomination Committee: Mr. Peter Immonen, Mr. Timo Leino, Mr. Mikko Mursula, Mr. Pekka Pajamo, chairman and Mr. Into Ylppö.

Oriola-KD and MSD BV Sign New Long-Term Cooperation Agreement in Finland

Oriola-KD and MSD BV have signed a new long-term cooperation agreement on 17 September 2015. According to the cooperation agreement, Oriola-KD offers MSD pharmaceutical storage and distribution services and a broad range of tailored services in Finland. MSD develops new and innovative pharmaceuticals. In Finland, it focuses on diabetes, immunology, oncology, infectious diseases, cardiovascular diseases and central nervous system disorders. MSD invests heavily in pharmaceutical research. In 2006-2014 MSD's investments in pharmaceutical research in Finland were approximately EUR 10 million annually and included more than 17,000 patients. The sales of MSD's pharmaceuticals at wholesale prices was EUR 136 million in Finland in 2014 (source: IMS Health).

Oriola-KD Corporation - Analyst/Investor Day

To provide information about company's updated strategy, new operating model and long-term financial targets


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
O5O:GR €4.10 EUR 0.00

O5O Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for O5O.
View Industry Companies

Industry Analysis


Industry Average

Valuation O5O Industry Range
Price/Earnings 14.7x
Price/Sales 0.4x
Price/Book 4.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORIOLA-KD OYJ B SHARES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at